Literature DB >> 12414347

Efficacy of Helicobacter pylori eradication in raising platelet count in adult patients with idiopathic thrombocytopenic purpura.

Dino Veneri1, Massimo Franchini, Michele Gottardi, Mariella D'Adda, Achille Ambrosetti, Mauro Krampera, Flavia Zanetti, Giovanni Pizzolo.   

Abstract

BACKGROUND AND OBJECTIVES: There are data consistent with an association between idiopathic thrombocytopenic purpura (ITP) and Helicobacter pylori (HP) infection. In addition, a significant increase of platelet count following HP eradication has been reported in a proportion of ITP patients. We describe here our experience on the efficacy of anti-HP treatment in ITP patients. DESIGN AND METHODS: Between December 1998 and May 2001 sixteen adult patients with ITP and documented HP infection were treated with standard antibiotic therapy for HP eradication (amoxicillin and clarithromycin plus pantoprazole combination). Of these patients, 7 had untreated ITP with mild/moderate thrombocytopenia (median platelet count 70x10(9)/L, range 41-91), 5 had relapsed following a previous steroid treatment (median platelet count 39x10(9)/L, range 30-90) and 4 were refractory to steroids (median platelet count 18.5x10(9)/L, range 9-30).
RESULTS: An improvement of platelet count was observed in 11/15 patients (73.3%) who achieved HP eradication. The difference between the mean platelet count SD before and after HP eradication was statistically significant (51.6 28.2x10(9)/L vs. 143.3 131.1x10(9)/L; p=0.01). Complete or partial responses were obtained in 11/16 treated patients (68.7%). This result still persisted after a median follow-up of 11.7 months. INTERPRETATION AND
CONCLUSIONS: Our data confirm the efficacy of Helicobacter pylori eradication in increasing platelet count in adult ITP patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414347

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

Review 1.  Helicobacter pylori and immune thrombocytopenic purpura: unsolved questions and controversies.

Authors:  Masataka Kuwana; Yasuo Ikeda
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 2.  Thrombocytopenias: a clinical point of view.

Authors:  Dino Veneri; Massimo Franchini; Federica Randon; Ilaria Nichele; Giovanni Pizzolo; Achille Ambrosetti
Journal:  Blood Transfus       Date:  2009-04       Impact factor: 3.443

Review 3.  Consequences of Helicobacter pylori infection in children.

Authors:  Lucia Pacifico; Caterina Anania; John F Osborn; Flavia Ferraro; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2010-11-07       Impact factor: 5.742

Review 4.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Rotavirus-associated immune thrombocytopenic purpura in children: A retrospective study.

Authors:  Qi Ai; Jing Yin; Sen Chen; Lijin Qiao; Na Luo
Journal:  Exp Ther Med       Date:  2016-08-09       Impact factor: 2.447

6.  Long term platelet responses to Helicobacter pylori eradication in Canadian patients with immune thrombocytopenic purpura.

Authors:  Shannon C Jackson; Paul Beck; Andre G Buret; Pamela M O'Connor; Jonathan Meddings; Graham Pineo; Man-Chiu Poon
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

7.  Prevalence of non-organ-specific autoantibodies in patients suffering from duodenal ulcer with and without Helicobacter pylori infection.

Authors:  Rinaldo Pellicano; Giovanni Antonio Touscoz; Antonina Smedile; Mara Berrutti; Giorgio Saracco; Alessandro Repici; Antonio Ponzetto; Mario Rizzetto
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

8.  Helicobacter pylori infection in patients with autoimmune thrombocytopenic purpura.

Authors:  Erdal Kurtoglu; Ertugrul Kayacetin; Aysegul Ugur
Journal:  World J Gastroenterol       Date:  2004-07-15       Impact factor: 5.742

9.  Clonally expanded T-cells in the peripheral blood of patients with idiopathic Thrombocytopenic purpura and Helicobacter pylori infection.

Authors:  Midori Ishiyama; Masanao Teramura; Koji Iwabe; Tomohiro Kato; Toshiko Motoji
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

10.  Outcome of immunosuppressive therapy with Helicobacter pylori eradication therapy in patients with chronic idiopathic thrombocytopenic purpura.

Authors:  Moo-Kon Song; Joo-Seop Chung; Ho-Jin Shin; Young-Jin Choi; Goon-Jae Cho
Journal:  J Korean Med Sci       Date:  2008-06       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.